Moxifloxacin Monotherapy in Left-Sided Staphylococcus aureus Endocarditis
Author(s) -
Yücel Çölkesen
Publication year - 2021
Publication title -
case reports in infectious diseases
Language(s) - English
Resource type - Journals
eISSN - 2090-6625
pISSN - 2090-6633
DOI - 10.1155/2021/5586450
Subject(s) - medicine , moxifloxacin , endocarditis , staphylococcus aureus , methicillin resistant staphylococcus aureus , regimen , antibiotics , infective endocarditis , surgery , staphylococcal infections , blood culture , microbiology and biotechnology , bacteria , genetics , biology
Staphylococcus aureus is the major cause of endocarditis, and its mortality has remained high despite therapeutic procedures over time. A case of left-sided native valve endocarditis caused by methicillin-sensitive Staphylococcus aureus which responded well to moxifloxacin monotherapy is described. An 83-year-old woman with a history of current hospitalization presented with fatigue and fever. Transthoracic echocardiography depicted vegetation, and blood cultures were positive for Staphylococcus aureus . After a 14-day intravenous administration of moxifloxacin, a good clinical response was achieved, and antibiotic regimen transitioned to oral moxifloxacin for an additional four-week therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom